(Il Sole 24 Ore Radiocor) - Milano, 15 gen - JP Morgan said that it has sold on behalf of the US pharmaceutical company Pfizer 700 million ordinary shares of consumer healthcare company Haleon at ...
(Alliance News) - Pfizer Inc sold 700 million shares in Haleon PLC, as planned, more than halving its remaining stake, placing agent JPMorgan Securiti ...
The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...
Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...
Haleon said in a prospectus filed earlier this week that it could face "possible liabilities" connected with OTC Zantac, although it is in the midst of indemnity negotiations with GSK and Pfizer ...
Cura Health, a leading provider in Kuwait's pharmaceutical and healthcare sector, today hosted a wellness event for its ...
The UK pharma group – now a therapeutics and vaccines pure-play since the spin-off of Haleon in July – also ... to market ahead of a rival jab from Pfizer, which is also anticipating ...
NEW YORK - Pfizer Inc. (NYSE:PFE) is set to sell approximately 700 million ordinary shares in Haleon plc, which represents about 7.7% of the consumer healthcare company's... Monday saw Bernstein ...
Pfizer (PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to induce ...
Pfizer (NYSE:PFE) has agreed to pay nearly $60M to resolve allegations that its Biohaven unit paid kickbacks to physicians to induce prescriptions for its migraine drug Nurtec ODT. The U.S ...
In a report released today, Iain Simpson from Barclays maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...
In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...